Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-04-06 00:00:00 ET · period of report 2022-04-04 · accession 0000899243-22-014117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-06 | 2022-04-04+ | VRTX | Lee Yuchun | Dir | S - Sale+OE | $270.11 | -4,000 | 1,875 | -68% | -$1.08M |
| DM | 2022-04-06 | 2022-04-04+ | VRTX | Lee Yuchun | Dir | M - OptEx | $81.54 | +4,000 | 3,875 | New | +$326.2K |
| DM | 2022-04-06 | 2022-04-04+ | VRTX | Lee Yuchun | Dir | M - OptEx | $81.54 | -4,000 | 18.0K | -18% | -$326.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-04 | S | D | 917 | $267.23 | 2,858 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $267.23 (range $266.85 to $267.79). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2022-04-04 | S | D | 100 | $265.83 | 3,775 | D | — | — | |
| 3 | Common | Common Stock | 2022-04-05 | M | A | 2,000 | $81.54 | 3,875 | D | — | — | |
| 4 | Common | Common Stock | 2022-04-05 | S | D | 17 | $268.30 | 3,858 | D | — | — | |
| 5 | Common | Common Stock | 2022-04-05 | S | D | 334 | $270.05 | 3,524 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $270.05 (range $269.79 to $270.64). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2022-04-05 | S | D | 488 | $271.94 | 3,036 | D | — | — | (F6) Open market sales reported on this line occurred at a weighted average price of $271.94 (range $271.35 to $272.27). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2022-04-05 | S | D | 600 | $272.60 | 2,436 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $272.60 (range $272.36 to $273.34). |
| 8 | Common | Common Stock | 2022-04-05 | S | D | 100 | $273.50 | 2,336 | D | — | — | |
| 9 | Common | Common Stock | 2022-04-05 | S | D | 461 | $274.66 | 1,875 | D | — | — | (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F8) Open market sales reported on this line occurred at a weighted average price of $274.66 (range $274.63 to $274.68). |
| 10 | Common | Common Stock | 2022-04-04 | S | D | 983 | $268.36 | 1,875 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $268.36 (range $267.97 to $268.81). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 11 | Common | Common Stock | 2022-04-04 | M | A | 2,000 | $81.54 | 3,875 | D | — | — | |
| 12 | Derivative | Stock Option (Right to Buy) | 2022-04-05 | M | D | 2,000 | $81.54 | 16,000 | D | $81.54 · — to 2023-05-31 | 2,000 Common Stock | (F9) Fully vested. |
| 13 | Derivative | Stock Option (Right to Buy) | 2022-04-04 | M | D | 2,000 | $81.54 | 18,000 | D | $81.54 · — to 2023-05-31 | 2,000 Common Stock | (F9) Fully vested. |